NASDAQ: CSBR - Champions Oncology, Inc.

Altı ay boyunca karlılık: -8.84%
Sektör: Healthcare

Promosyon programı Champions Oncology, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.

Daha fazla ayrıntı
In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

Выручка 0.0271
EBITDA 0.000876
Число акций ао 0.01354 млрд
P/E 1001.04
P/S 4.73
P/BV 57.25
EV/EBITDA 142.59
Цена ао 5.02
ISIN US15870P3073
Сайт https://www.championsoncology.com
Валюта usd
IPO date 2003-01-10
Sector Health Care
Industry Life Sciences Tools & Services
Валюта отчета usd
Günlük fiyat değişimi: +0.6652% (4.51)
Haftalık fiyat değişimi: -5.61% (4.81)
Aylık fiyat değişimi: +8.51% (4.184)
3 ayda fiyat değişimi: -10.1% (5.05)
Altı ayda fiyat değişimi: -8.84% (4.98)
Yıllık fiyat değişimi: -26.77% (6.2)
3 yılda fiyat değişimi: -56.76% (10.5)
5 yılda fiyat değişimi: -20.77% (5.73)
Yılbaşından bu yana fiyat değişimi: -17.9% (5.53)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 1.27 9
P/BV 14.78 1
P/E 197.15 1
EV/EBITDA -48 0
Toplam: 3.25

Yeterlik

İsim Anlam Seviye
ROA, % -15.55 0
ROE, % -115.08 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -6.16 10
Toplam: 9.4

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 56.25 7
karlılık Ebitda, % 1540.91 10
karlılık EPS, % 221.98 10
Toplam: 7.4
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Battery Management Corp. 2421673 17.81
NEA Management Company, LLC 1713720 12.61
Tocqueville Asset Management L.P. 684578 5.04
Renaissance Technologies, LLC 124791 0.92
Blackrock Inc. 116097 0.85
Vanguard Group Inc 82837 0.61
Essex Investment Management Co LLC 77200 0.57
Ameriprise Financial, Inc. 75044 0.55
Geode Capital Management, LLC 61349 0.45
Northern Trust Corporation 44917 0.33

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
iShares Micro-Cap ETF 0.00839 36.318555985322 1.54048



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Ronnie Morris M.D. CEO & Director 600k 1966 (58 yıllar)
Mr. David Barry Miller M.B.A. Chief Financial Officer 285k 1969 (55 yıllar)
Mr. Brady Davis President N/A 1969 (55 yıllar)
Dr. Maria Mancini Ph.D. Chief Operating Officer N/A
Mr. Arthur Hanson Vice President of Technology N/A
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS Vice President of Global Marketing N/A
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG Executive Vice President of Global Laboratory Operations N/A
Dr. Michael Ritchie M.B.A., Ph.D. Chief Commercial Officer N/A
Dr. Karin Abarca Heidemann Ph.D. Executive Vice President of Global Scientific Operations N/A
Dr. Marianna Zipeto Ph.D. Executive Vice President of Commercial, Research Services & Partnering N/A

Adres: United States, Hackensack. NJ, One University Plaza - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.championsoncology.com